Fifth Third Bancorp »

Marker Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2025-12-31 $15k 10k 1.49

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr S&p 100 Etf (OEF)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Abbvie (ABBV)

View all positions for Fifth Third Bancorp

Top funds holding Marker Therapeutics

NEA Management Company
Blue Owl Capital Holdings
Vanguard Group
Aisling Capital Management
UBS Group
Goss Wealth Management
Geode Capital Management
Renaissance Technologies
Advisor Group Holdings
LPL Financial
XTX Topco
Jane Street
Boyer Financial Services
Two Sigma Investments
Invst

View all funds holding Marker Therapeutics